AstraZeneca vaccine is 79 pct effective against symptomatic Covid-19, says company
Mar 22, 2021
Washington [US] March 22 : AstraZeneca's Covid-19 vaccine showed 79 per cent efficacy against symptomatic disease and 100 per cent efficacy against severe disease and hospitalisation in a new, US-based clinical trial, the company said Monday.